NCT06685848View on ClinicalTrials.gov

Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion

NARecruitingINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

November 29, 2024

Primary Completion Date

December 15, 2026

Study Completion Date

December 15, 2026

Conditions

Hematologic Neoplasms

Interventions

DEVICE

Hemanext ONE system

Hypoxic red blood cells

DEVICE

Conventional RBCs

Conventional manufactured Red blood cells

Trial Locations (1)

5021

RECRUITING

Haukeland University Hospital, Bergen

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Hemanext

INDUSTRY